CDC25 Inhibition in Acute Myeloid Leukemia–A Study of Patient Heterogeneity and the Effects of Different Inhibitors

بواسطة Brenner, Annette K., Reikvam, Håkon, Rye, Kristin Paulsen, Hagen, Karen Marie, Lavecchia, Antonio, Bruserud, Øystein
الحاوية / القاعدة Molecules (2017)

Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular...

بواسطة Bruserud, Øystein, Reikvam, Håkon, Fredly, Hanne, Skavland, Jørn, Hagen, Karen-Marie, van Hoang, Tuyen Thy, Brenner, Annette K., Kadi, Amir, Astori, Audrey, Gjertsen, Bjørn Tore, Pendino, Frederic
الحاوية / القاعدة Oncotarget (2014)

Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells

بواسطة Nepstad, Ina, Hatfield, Kimberley Joanne, Grønningsæter, Ida Sofie, Aasebø, Elise, Hernandez-Valladares, Maria, Hagen, Karen Marie, Rye, Kristin Paulsen, Berven, Frode S., Selheim, Frode, Reikvam, Håkon, Bruserud, Øystein
الحاوية / القاعدة Signal Transduct Target Ther (2019)

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome

بواسطة Kittang, Astrid Olsnes, Kordasti, Shahram, Sand, Kristoffer Evebø, Costantini, Benedetta, Kramer, Anne Marijn, Perezabellan, Pilar, Seidl, Thomas, Rye, Kristin Paulsen, Hagen, Karen Marie, Kulasekararaj, Austin, Bruserud, Øystein, Mufti, Ghulam J.
الحاوية / القاعدة Oncoimmunology (2015)

CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia

بواسطة Astori, Audrey, Fredly, Hanne, Aloysius, Thomas Aquinas, Bullinger, Lars, Mas, Véronique Mansat-De, de la Grange, Pierre, Delhommeau, François, Hagen, Karen Marie, Récher, Christian, Dusanter-Fourt, Isabelle, Knappskog, Stian, Lillehaug, Johan Richard, Pendino, Frédéric, Bruserudg, Øystein
منشور في 2013